Losartan exerts no protective effects against acute pulmonary embolism-induced hemodynamic changes (2012)
- Authors:
- Autor USP: SANTOS, JOSE EDUARDO TANUS DOS - FMRP
- Unidade: FMRP
- DOI: 10.1007/s00210-011-0695-x
- Subjects: ANGIOTENSINA II; PRESSÃO SANGUÍNEA (EFEITOS DE DROGAS); EMBOLIA PULMONAR (COMPLICAÇÕES); RESISTÊNCIA VASCULAR
- Language: Inglês
- Imprenta:
- Publisher place: Heidelberg
- Date published: 2012
- Source:
- Título do periódico: Naunyn-Schmiedeberg's Archives of Pharmacology
- ISSN: 0028-1298
- Volume/Número/Paginação/Ano: v. 385, n. 2, p. 211-217, 2012
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
DIAS JÚNIOR, Carlos A. et al. Losartan exerts no protective effects against acute pulmonary embolism-induced hemodynamic changes. Naunyn-Schmiedeberg's Archives of Pharmacology, v. 385, n. 2, p. 211-217, 2012Tradução . . Disponível em: https://doi.org/10.1007/s00210-011-0695-x. Acesso em: 28 jul. 2024. -
APA
Dias Júnior, C. A., Neto-Neves, E. M., Montenegro, M. F., & Tanus-Santos, J. E. (2012). Losartan exerts no protective effects against acute pulmonary embolism-induced hemodynamic changes. Naunyn-Schmiedeberg's Archives of Pharmacology, 385( 2), 211-217. doi:10.1007/s00210-011-0695-x -
NLM
Dias Júnior CA, Neto-Neves EM, Montenegro MF, Tanus-Santos JE. Losartan exerts no protective effects against acute pulmonary embolism-induced hemodynamic changes [Internet]. Naunyn-Schmiedeberg's Archives of Pharmacology. 2012 ; 385( 2): 211-217.[citado 2024 jul. 28 ] Available from: https://doi.org/10.1007/s00210-011-0695-x -
Vancouver
Dias Júnior CA, Neto-Neves EM, Montenegro MF, Tanus-Santos JE. Losartan exerts no protective effects against acute pulmonary embolism-induced hemodynamic changes [Internet]. Naunyn-Schmiedeberg's Archives of Pharmacology. 2012 ; 385( 2): 211-217.[citado 2024 jul. 28 ] Available from: https://doi.org/10.1007/s00210-011-0695-x - Pharmacokinetics and QT interval pharmacodynamics of oral haloperidol in poor and extensive metabolizers of CYP2D6
- Sequence diversity and functional charactterization of the 5´-regulatory region of human cyp2c19
- Uncontrolled hypertension, uncompensated type II diabetes, and smoking have different patterns of vascular dysfunction
- Nitrate decreases xanthine oxidoreductase-mediated nitrite reductase activity and attenuates vascular and blood pressure responses to nitrite
- eNOS gene polymorphirms may modify the effects produced by cardiovascular drugs on myocardial eNOS expression and activity [Carta]
- Modulation of nitric oxide formation by endothelial nitric oxide synthase gene haplotypes
- Hemodynamic effects of bupropion in anesthetized dogs
- Hemodynamic effects of sildenafil interaction with a nitric oxide donor compound in a dog model of acute pulmonary embolism
- Severity dependent increases in circulating cardiac troponin I and MMP-9 concentrations after experimental acute pulmonary thromboembolism
- Functional polymorphism located in MMP-9 gene promoter is strongly associated with obesity
Informações sobre o DOI: 10.1007/s00210-011-0695-x (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
